Erick Lucera
CIK 1697616 · Chief Financial Officer · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.44M
Companies
7
Total Filings
42
Lifetime Open-Market Net
-$247.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Chief Financial Officer | 121,563 | $25.90 | $3.15M | -$181.5K | 5 | 2026-06-26 |
| SABSW | Director | — | $0.01 | — | $0 | 3 | 2025-12-18 |
| XAIR | Director | 109 | $5.46 | $595 | $29.2K | 10 | 2025-11-06 |
| EDIT | EVP, CHIEF FINANCIAL OFFICER | 112,720 | $2.62 | $295.3K | -$132.4K | 5 | 2025-03-27 |
| BBLGW | Director | — | $10.00 | — | $0 | 3 | 2023-09-20 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Chief Financial Officer | — | $15.00 | — | $0 | 4 | 2023-01-19 |
| Valeritas Holdings Inc. (VLRX) Delisted | See Remarks | 225 | — | — | $37.4K | 5 | 2019-03-08 |
Recent Filings · Page 2 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-28 | XAIR | Grant (A) | — | $0 | EDGAR |
| 2025-03-27 | EDIT | Grant (A) | — | $0 | EDGAR |
| 2025-03-05 | EDIT | Sell (S) | −4,109 | -$7.0K | EDGAR |
| 2025-02-28 | EDIT | Notice (144) | −8,000 | -$14.9K | EDGAR |
| 2024-11-26 | XAIR | Mixed | — | $0 | EDGAR |
| 2024-08-15 | XAIR | Buy (P) | +39,266 | $15.6K | EDGAR |
| 2024-07-17 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2024-05-22 | EDIT | Sell (S) | −22,337 | -$125.4K | EDGAR |
| 2024-05-17 | EDIT | Notice (144) | −45,000 | -$256.9K | EDGAR |
| 2024-03-21 | XAIR | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.